SUNNYVALE, Calif. , Jan. 8, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Needham Growth Conference in New York on Wednesday, January 16, 2013 at 8:00 a.m. EST / 5:00 a.m.
Conference Call at 5:00 p.m. EST Today SUNNYVALE, Calif. , Jan. 3, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today preliminary results for the second quarter of fiscal 2013 that ended December 31, 2012 and updated guidance for fiscal 2013.
SUNNYVALE, Calif. , Dec. 20, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its president and chief executive officer, Joshua H. Levine , is scheduled to present at the J.P. Morgan Healthcare Conference in San Francisco on
SUNNYVALE, Calif. , Dec. 6, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Oppenheimer Healthcare Conference in New York on Thursday, December 13, 2012 at 11:10 a.m.
SUNNYVALE, Calif. , Nov. 20, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Piper Jaffray Healthcare Conference in New York on Wednesday, November 28, 2012 at 8:30 a.m.
SUNNYVALE, Calif. , Nov. 9, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that its management is scheduled to present at the Lazard Capital Markets Healthcare Conference in New York on Tuesday, November 13, 2012 at 3:30 p.m.
Presentations Highlight the Unmatched Clinical Excellence and Broad Range of Applications for the CyberKnife® and TomoTherapy® Systems SUNNYVALE, Calif. , Nov. 8, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today that studies
Transformative Technology Launch at Leading Radiation Oncology Meeting Sets Stage for Future Growth SUNNYVALE, Calif. , Nov. 7, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today financial results for the first quarter of fiscal 2013
The CyberKnife System, with its Unique Ability to Track and Correct for Motion During Treatment, Demonstrates Strong Results in Prostate Cancer SUNNYVALE, Calif. , Nov. 5, 2012 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, announced today clinical
CyberKnife M6Series Offers Unmatched Clinical Capabilities and Increased Efficiency, Extending its Radiosurgical Accuracy to a Broader Field of Applications SUNNYVALE, Calif., Nov. 1, 2012 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, today
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
